Persistence and emergence of X4 virus in HIV infection

Mathematical Biosciences and Engineering

Volumn 8, Issue 2, 2011, Pages 605-626

  Weinberger, Ariel D ^a   Perelson, Alan S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

Coreceptor; HIV; Phenotypic switch; R5; X4

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5;

ANIMAL; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; CLASSIFICATION; COMPUTER SIMULATION; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; VIROLOGY; VIRUS ACTIVATION; VIRUS LOAD;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPUTER SIMULATION; HIV INFECTIONS; HIV-1; HUMANS; MODELS, IMMUNOLOGICAL; RECEPTORS, CCR4; RECEPTORS, CCR5; VIRAL LOAD; VIRUS ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79955037084     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2011.8.605     Document Type: Conference Paper

References (70)

1. H. Blaak, A. B. van't Wout, M. Brouwer, B. Hooibrink, E. Hovenkamp and H. Schuitemaker, In vivo HIV-1 infection of CD45RA (+) CD4 (+) T cells is established primarily by syncytiuminducing variants and correlates with the rate of CD4 (+) T cell decline, Proc. Natl. Acad. Sci. U. S. A., 97(2000), 1269-1274. (Pubitemid 30080848)
2. D. S. Callaway, R. M. Ribeiro and M. A. Nowak, Virus phenotype switching and disease progression in HIV-1 infection, Proc. Roy. Sci. B, 266(1999), 2523-2530. (Pubitemid 30034908)
3. C. H. Casper, P. Clevestig, E. Carlenor, T. Leitner, B. Anzén, K. Lidman, E. Belfrage, J. Albert, A. B. Bohlin, L. Navér, S. Lindgren, E. M. Fenyö and A. C. Ehrnst, Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child, J. Infect. Dis., 186(2002), 914-921.
4. L. A. Chakrabarti, S. R. Lewin, L. Zhang, A. Gettie, A. Luckay, L. N. Martin, E. Skulsky, D. D. Ho, C. Cheng-Mayer and P. A. Marx, Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection, J. Virol., 74(2000), 1209-1223. (Pubitemid 30044070)
5. H. Y. Chen, M. Di Mascio, A. S. Perelson, D. D. Ho and L. Zhang, Determination of virus burst size in vivo using a single-cycle SIV in rhesus macaques, Proc. Natl. Acad. Sci. U. S. A., 104(2007), 19079-19084.
6. E. Coakley, C. J. Petropoulos and J. M. Whitcomb, Assessing chemokine co-receptor usage in HIV, Curr. Opin. Infect. Dis., 18(2005), 9-15. (Pubitemid 41716234)
7. M. Cornelissen, G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. van der Hoek, C. Sol and R. Coutinho, Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population, J. Virol., 69(1995), 1810-1818.
8. M. P. Davenporta, J. J. Zaundersb, M. D. Hazenbergc, H. Schuitemakerc and R. P. van Rijc, Cell turnover and cell tropism in HIV-1 infection, Trends Microbiol., 10(2002), 275-278.
9. P. Delobel, K. Sandres-Sauné, M. Cazabat, C. Pasquier, B. Marchou, P. Massip and J. Izopet, R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy, J. Acquir. Immune. Defic. Syndr., 38(2005), 382-392. (Pubitemid 40381547)
10. D. C. Douek, Disrupting T-cell homeostasis: How HIV-1 infection causes disease, AIDS Rev., 5(2003), 172-177. (Pubitemid 37336634)
11. D. C. Douek, L. J. Picker and R. A. Koup, T cell dynamics in HIV-1 infection, Annu. Rev. Immunol., 21(2003), 265-304. (Pubitemid 37174533)
12. O. Equils, E. Garratty, L. S. Wei, S. Plaeger, M. Tapia, J. Deville, P. Krogstad, S. Myung-Shin, K. Nielsen and Y. J. Bryson, Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy, J. Infect. Dis., 182(2000), 751-757.
13. J. M. Farber and E. A. Berger, HIV's response to a CCR5 inhibitor: I'd rather tighten than switch!, Proc. Natl. Acad. Sci. U. S. A., 99(2002), 1749-1751. (Pubitemid 34168960)
14. J. V. Giorgi, L. E. Hultin, J. A. McKeating, T. D. Johnson, B. Owens, L. P. Jacobson, R. Shih, J. Lewis, D. J. Wiley, J. P. Phair, S. M. Wolinsky and R. Detels, Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage, J. Infect. Dis., 179(1999), 859-870. (Pubitemid 29159331)
15. F. Gondois-Rey, A. Biancotto, M. A. Fernandez, L. Bettendroffer, J. Blazkova, K. Trejbalova, M. Pion and I. Hirsch, R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L-CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors, J. Virol., 80(2006), 854-865. (Pubitemid 43062897)
16. F. Gondois-Rey, J. C. Grivel, A. Biancotto, M. Pion, R. Vigne, L. B. Margolis and I. Hirsch, Segregation of R5 and X4 HIV-1 variants to memory T cell subsets differentially expressing CD62L in ex vivo infected human lymphoid tissue, AIDS, 16(2002), 1245-1249. (Pubitemid 34666658)
17. A. T. Haase, Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues, Annu. Rev. Immunol., 17(1999), 625-656. (Pubitemid 29241136)
18. A. T. Haase, K. Henry, M. Zupancic, G. Sedgewick, R. A. Faust, H. Melroe, W. Cavert, K. Gebhard, K. Staskus, Z. Q. Zhang, P. J. Dailey, H. H. Balfour Jr, A. Erice and A. S. Perelson, Quantitative image analysis of HIV-1 infection in lymphoid tissue, Science, 274(1996), 985-989. (Pubitemid 26398421)
19. J. M. Harouse, C. Buckner, A. Gettie, R. Fuller, R. Bohm, J. Blanchard and C. Cheng-Mayer, CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques, Proc. Natl. Acad. Sci. U. S. A., 100(2003), 10977-10982. (Pubitemid 37140138)
20. M. D. Hazenberg, S. A. Otto, J. W. Cohen Stuart, M. C. Verschuren, J. C. Borleffs, C. A. Boucher, R. A. Coutinho, J. M. Lange, T. F. Rinke de Wit, A. Tsegaye, J. J. van Dongen, D. Hamann, R. J. de Boer and F. Miedema, Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection, Nat. Med., 6(2000), 1036-1042.
21. M. D. Hazenberg, S. A. Otto, D. Hamann, M. T. Roos, H. Schuitemaker, R. J. de Boer and F. Miedema, Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation, AIDS, 17(2003), 1419-1424. (Pubitemid 36900541)
22. M. D. Hazenberg, S. A. Otto, B. H. van Benthem, M. T. Roos, R. A. Coutinho, J. M. Lange, D. Hamann, M. Prins and F. Miedema, Persistent immune activation in HIV-1 infection is associated with progression to AIDS, AIDS, 17(2003), 1881-1888. (Pubitemid 37070273)
23. M. D. Hazenberg, J. W. Stuart, S. A. Otto, J. C. Borleffs, C. A. Boucher, R. J. de Boer, F. Miedema and D. Hamann, T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: A longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART), Blood, 95(2000), 249-255. (Pubitemid 30017249)
24. R. L. Hengel, V. Thaker, M. V. Pavlick, J. A. Metcalf, G. Dennis Jr, J. Yang, R. A. Lempicki, I. Sereti and H. C. Lane, Cutting edge: L-selectin (CD62L) expression distinguishes small resting memory CD4+ T cells that preferentially respond to recall antigen, J. Immunol., 170(2003), 28-32. (Pubitemid 36026119)
25. D. D. Ho, A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard and M. Markowitz, Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature, 373(1995), 123-126.
26. S. H. Ho, L. Shek, A. Gettie, J. Blanchard and C. Cheng-Mayer, V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques, J. Virol., 79(2005), 12296-12303. (Pubitemid 41346091)
27. M. Joly and J. M. Pinto, CXCR4 and CCR5 regulation and expression patterns on T-and monocyte-macrophage cell lineages: Implications for susceptibility to infection by HIV-1, Math. Biosci., 195(2005), 92-126. (Pubitemid 40726364)
28. E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson, S. Wang, H. Li, X. Wei, C. Jiang, J. L. Kirchherr, F. Gao, J. A. Anderson, L. H. Ping, R. Swanstrom, G. D. Tomaras, W. A. Blattner, P. A. Goepfert, J. M. Kilby, M. S. Saag, E. L. Delwart, M. P. Busch, M. S. Cohen, D. C. Montefiori, B. F. Haynes, B. Gaschen, G. S. Athreya, H. Y. Lee, N. Wood, C. Seoighe, A. S. Perelson, T. Bhattacharya, B. T. Korber, Hahn B. H. and G. M. Shaw, Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection, Proc. Natl. Acad. Sci. U. S. A., 105(2008), 7552-7557. (Pubitemid 351830056)
29. B. Lee M. Sharron, L. J. Montaner, D. Weissman and R. W. Doms, Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages, Proc. Natl. Acad. Sci. U. S. A., 96(1999), 5215-5220. (Pubitemid 29214563)
30. Q. Li, L. Duan, J. D. Estes, Z. M. Ma, T. Rourke, Y. Wang, C. Reilly, J. Carlis, C. J. Miller and A. T. Haase, Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, 434(2005), 1148-1152. (Pubitemid 40663495)
31. A. J. Low, W. Dong, D. Chan, T. Sing, R. Swanstrom, M. Jensen, S. Pillai, B. Good and P. R. Harrigan, Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates, Aids, 21(2007), F17-24. (Pubitemid 47329758)
32. L. M. Mansky and H. M. Temin, Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase, J. Virol., 69(1995), 5087-5094.
33. M. Markowitz, M. Louie, A. Hurley, E. Sun, M. Di Mascio, A. S. Perelson and D. D. Ho, A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo, J. Virol., 77(2003), 5037-5038. (Pubitemid 36402857)
34. T. Melby, M. Despirito, R. Demasi, G. Heilek-Snyder, M. L. Greenberg and N. Graham, HIV-1 coreceptor use in triple-class treatment-experienced patients: Baseline prevalence, correlates, and relationship to enfuvirtide response, J. Infect. Dis., 194(2006), 238-246. (Pubitemid 44087196)
35. H. Mohri, S. Bonhoeffer, S. Monard, A. S. Perelson and D. D. Ho, Rapid turnover of T lymphocytes in SIV-infected rhesus macaques, Science, 279(1998), 1223-1227. (Pubitemid 28164377)
36. H. Mohri, A. S. Perelson, K. Tung, R. M. Ribeiro, B. Ramratnam, M. Markowitz, R. Kost, A. Hurley, L. Weinberger, D. Cesar, M. K. Hellerstein and D. D. Ho, Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy, J. Exp. Med., 194(2001), 1277-1287. (Pubitemid 33055046)
37. J. P. Moore, S. G. Kitchen, P. Pugach and J. A. Zack, The CCR5 and CXCR4 coreceptors-central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection, AIDS Res. Hum. Retroviruses., 20(2004), 111-126. (Pubitemid 38147183)
38. M. Paiardini, I. Frank, I. Pandrea, C. Apetrei and G. Silvestri, Mucosal immune dysfunction in AIDS pathogenesis, AIDS Rev., 10(2008), 36-46. (Pubitemid 351524050)
39. C. Pastore, R. Nedellec, A. Ramos, S. Pontow, L. Ratner and D. E. Mosier, Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations, J. Virol., 80(2006), 750-758. (Pubitemid 43062887)
40. M. L. Penn, J. C. Grivel, B. Schramm, M. A. Goldsmith and L. Margolis, CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue, Proc. Natl. Acad. Sci. U. S. A., 96(1999), 663-668. (Pubitemid 29061265)
41. A. S. Perelson, A. U. Neumann, M. Markowitz, J. M. Leonard and D. D. Ho, HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time, Science, 271(1996), 1582-1586. (Pubitemid 26097216)
42. S. Philpott, B. Weiser, K. Anastos, C. M. Kitchen, E. Robison, W. A. Meyer, H. S. Sacks, U. Mathur-Wagh, C. Brunner and H. Burger Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy, J. Clin. Invest., 107(2001), 431-438. (Pubitemid 32167989)
43. B. Ramratnam, S. Bonhoeffer, J. Binley, A. Hurley, L. Zhang, J. E. Mittler, M. Markowitz, J. P. Moore, A. S. Perelson and D. D. Ho, Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis, Lancet, 354(1999), 1782-1785.
44. R. Regoes and S. Bonhoeffer, HIV coreceptor usage and drug treatment, J. Theor. Biol., 217(2002), 443-457. (Pubitemid 35191762)
45. R. R. Regoes and S. Bonhoeffer, The HIV coreceptor switch: A population dynamical perspective, Trends Microbiol., 13(2005), 269-277. (Pubitemid 40779815)
46. R. M. Ribeiro, M. D. Hazenberg, A. S. Perelson and M. P. Davenport, Naive and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: Implications for therapy, J. Virol., 80(2006), 802-809. (Pubitemid 43062892)
47. D. D. Richman and S. A. Bozzette, The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression, J. Infect. Dis., 169(1994), 968-974. (Pubitemid 24303213)
48. N. Sachsenberg, A. S. Perelson, S. Yerly, G. A. Schockmel, D. Leduc, B. Hirschel and L. Perrin, Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen, J. Exp. Med., 187(1998), 1295-1303. (Pubitemid 28189118)
49. H. Schuitemaker, M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. de Goede, R. P. van Steenwijk, J. M. Lange, J. K. Schattenkerk, F. Miedema and M. Tersmette, Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population, J. Virol., 66(1992), 1354-1360.
50. G. Silvestri, Naturally SIV-infected sooty mangabeys: Are we closer to understanding why they do not develop AIDS?, J. Med. Primatol., 34(2005), 243-252. (Pubitemid 41179586)
51. G. Silvestri, M. Paiardini, I. Pandrea, M. M. Lederman and D. L. Sodora, Understanding the benign nature of SIV infection in natural hosts, J. Clin. Invest., 117(2007), 3148-3154. (Pubitemid 350096967)
52. G. Silvestri, D. L. Sodora, R. A. Koup, M. Paiardini, S. P. O'Neil, H. M. McClure, S. I. Staprans and M. B. Feinberg, Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia, Immunity, 18(2003), 441-452. (Pubitemid 36351522)
53. K. Skrabal, V. Trouplin, B. Labrosse, V. Obry, F. Damond, A. J. Hance, F. Clavel and F. Mammano, Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations, Aids, 17(2003), 809-814. (Pubitemid 36547652)
54. I. J. Spijkerman, M. Koot, M. Prins, I. P. Keet, A. J. van den Hoek, F. Miedema and R. A. Coutinho, Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men, Aids, 9(1995), 1085-1092.
55. A. Suarez, L. Mozo and C. Gutierrez, Generation of CD4 (+) CD45RA (+) effector T cells by stimulation in the presence of cyclic adenosine 5'-monophosphate-elevating agents, J. Immunol., 169(2002), 1159-1167. (Pubitemid 34809155)
56. J. C. Tilton, H. Amrine-Madsen, J. L. Miamidian, K. M. Kitrinos, J. Pfaff, J. F. Demarest, N. Ray, J. L. Jeffrey, C. C. Labranche and R. W. Doms, HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry, AIDS Res. Hum. Retroviruses, 26, 13-24.
57. A. Trkola, S. E. Kuhmann, J. M. Strizki, E. Maxwell, T. Ketas, T. Morgan, P. Pugach, S. Xu, L. Wojcik, J. Tagat, A. Palani, S. Shapiro, J. W. Clader, S. McCombie, G. R. Reyes, B. M. Baroudy and J. P. Moore, HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use, Proc. Natl. Acad. Sci. U. S. A., 99(2002), 395-400. (Pubitemid 34060372)
58. A. M. Tsibris and D. R. Kuritzkes, Chemokine antagonists as therapeutics: Focus on HIV-1, Annu. Rev. Med., 58(2007), 445-459. (Pubitemid 46706526)
59. D. Unutmaz, F. Baldoni and S. Abrignani, Human naive T cells activated by cytokines differentiate into a split phenotype with functional features intermediate between naive and memory T cells, Int. Immunol., 7(1995), 1417-1424.
60. D. Unutmaz, P. Pileri and S. Abrignani, Antigen-independent activation of naive and memory resting T cells by a cytokine combination, J. Exp. Med., 180(1994), 1159-1164. (Pubitemid 24256630)
61. R. S. Veazey, K. G. Mansfield, I. C. Tham, A. C. Carville, D. E. Shvetz, A. E. Forand and A. A. Lackner, Dynamics of CCR5 expression by CD4 (+) T cells in lymphoid tissues during simian immunodeficiency virus infection, J. Virol., 74(2000), 11001-11007. (Pubitemid 32223965)
62. X. Wei, S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak and B. H. Hahn, Viral dynamics in human immunodeficiency virus type 1 infection, Nature, 373(1995), 117-122.
63. A. D. Weinberger, A. S. Perelson, R. M. Ribeiro and L. S. Weinberger, Accelerated immunodeficiency by anti-CCR5 treatment in HIV infection, PLoS Comput. Biol., 5(2009), e1000467.
64. L. S. Weinberger, D. V. Schaffer and A. P. Arkin, Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection, J. Virol., 77(2003), 10028-10036. (Pubitemid 37122084)
65. M. Westby, M. Lewis, J. Whitcomb, M. Youle, A. L. Pozniak, I. T. James, T. M. Jenkins, M. Perros and E. van der Ryst, Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir, J. Virol., 80(2006), 4909-4920.
66. M. Westby and E. van der Ryst, CCR5 antagonists: Host-targeted antivirals for the treatment of HIV infection, Antivir. Chem. Chemother., 16(2005), 339-354. (Pubitemid 41746045)
67. D. Wodarz, A. L. Lloyd, V. A. Jansen and M. A. Nowak, Dynamics of macrophage and T cell infection by HIV, J. Theor. Biol., 196(1999), 101-113. (Pubitemid 29017553)
68. D. Wodarz and M. A. Nowak, The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV, Proc. Roy. Sci. B, 265(1998), 2149-2158. (Pubitemid 28528505)
69. S. M. Wolinsky, R. S. Veazey, K. J. Kunstman, P. J. Klasse, J. Dufour, A. J. Marozsan, M. S. Springer and J. P. Moore, Effect of a CCR5 inhibitor on viral loads in macaques dualinfected with R5 and X4 primate immunodeficiency viruses, Virology, 328(2004), 19-29. (Pubitemid 39221908)
70. Z. Q. Zhang, S. W. Wietgrefe, Q. Li, M. D. Shore, L. Duan, C. Reilly, J. D. Lifson and A. T. Haase, Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection, Proc. Natl. Acad. Sci. USA, 101(2004), 5640-5645. (Pubitemid 38481209)